Azenta, Inc. (FRA:BA3)

Market Cap	1.14B -51.4%
Revenue (ttm)	506.78M +2.7%
Net Income	-51.27M
EPS	-1.12
Shares Out	n/a
PE Ratio	n/a
Forward PE	31.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	23
Open	25.00
Previous Close	24.60
Day's Range	24.80 - 25.00
52-Week Range	21.80 - 45.00
Beta	n/a
RSI	35.84
Earnings Date	Feb 4, 2026

About Azenta

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sampl...

• Industry: Commercial Physical and Biological Research
• Founded: 1978
• Employees: 3,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BA3

Financial Performance

In fiscal year 2025, Azenta's revenue was $593.82 million, an increase of 3.55% compared to the previous year's $573.45 million. Losses were -$55.76 million, -66.18% less than in 2024.

Financial numbers in USD